Teva Pharmaceutical: Predictable Growth, Good Value | Free Investing

Teva Pharmaceutical: Predictable Growth, Good Value

Submitted by Free Investing on Thu, 08/20/2009 - 02:31

Chuck Carnevale submits:HistoryConventional wisdom would indicate that finding a sure thing in the stock market is an impractical dream. However, Teva Pharmaceutical Industries, Ltd. (TEVA) may be as close as you will ever get. As one of the top 20 pharmaceutical companies in the world this leader in generic and biogenerics is well positioned to prosper in today’s healthcare environment.Teva, however, is much more than just the largest generic manufacturer and distributor; they also are one of the most innovative participants in the important fields of neurology for treatments of devastating diseases, other autoimmune diseases, and oncology.Complete Story »

All original content is Free and Open.
All syndicated content is © the original authors.

Countries for Investment: Argentina, Australia, Belarus, Belize, Bolivia, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, England, Finland, France, Germany, Guatemala, Honduras, Iceland, India, Iraq, Iran, Ireland, Israel, Italy, Japan, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Pakistan, Paraguay, Peru, Philippines, Poland, Portugal, Russia, Scotland, Slovakia, Slovenia, Sweden, Syria, Thailand, Turkey, Ukraine, United Arabic Emirates, Uruguay, Venezuela, Vietnam and others.

US States for Investing: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming